-
Research and Development
At the core of ALK, innovation thrives. Our R&D function develops world class therapies for allergy management in a collaborative environment. Fostering new insights into research, this function is shaping the future of allergy treatment.
-
Product Supply
ALK's Product Supply team helps ensure smooth global delivery of allergy treatments, meeting market needs and demands, while collaborating as a dynamic and international Product Supply team
-
Global Quality
In our Global Quality team, colleagues worldwide are ensuring the highest standards in product safety and efficiency, driving continuous improvements and compliance cross the organisation.
-
Commercial Operations
ALK's passionate Commercial Operations team drive our international sales growth with a strong focus on our purpose to help adults and children with allergy. If you hrive in a professional sales focused environment this team is for you.
-
People & Organisation
People & Organisation is a global team, driving a thriving workplace culture across borders and functions, supporting employee development, and enhancing engagement for all ALK colleagues






At the core of ALK, innovation thrives. We have spent the past 100+ years pioneering within the field of allergy with the continued purpose of helping more people living with allergy.
Our deep understanding of the underlying biology and how allergy works has given us the foundation to develop a range of allergy immunotherapy treatments and management options, forming the core of our current product range. We remain committed to advancing science and are dedicated to innovate and expand our Research & Development (R&D) pipeline, continuously providing novel concepts within allergy research and treatment.
Our scientific focus is centered around respiratory allergy, food allergy, anaphylaxis and adjacent diseases areas.
Are you a young scientist making significant contributions within the field of allergy research? Apply for the prestigious Henning Løwenstein Research Award 2025 now! Deadline is 15 August 2025.




